223 related articles for article (PubMed ID: 33150379)
1. CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation.
de Koning C; Prockop S; van Roessel I; Kernan N; Klein E; Langenhorst J; Szanto C; Belderbos M; Bierings M; Boulad F; Bresters D; Cancio M; Curran K; Kollen W; O'Reilly R; Scaradavou A; Spitzer B; Versluijs B; Huitema A; Lindemans C; Nierkens S; Boelens JJ
Blood; 2021 Feb; 137(6):848-855. PubMed ID: 33150379
[TBL] [Abstract][Full Text] [Related]
2. Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation.
Admiraal R; de Koning CCH; Lindemans CA; Bierings MB; Wensing AMJ; Versluys AB; Wolfs TFW; Nierkens S; Boelens JJ
J Allergy Clin Immunol; 2017 Dec; 140(6):1643-1650.e9. PubMed ID: 28392330
[TBL] [Abstract][Full Text] [Related]
3. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
[TBL] [Abstract][Full Text] [Related]
4. Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients.
Lakkaraja M; Mauguen A; Boulad F; Cancio MI; Curran KJ; Harris AC; Kernan NA; Klein E; Kung AL; Oved J; Prockop S; Scaradavou A; Spitzer B; O'Reilly RJ; Boelens JJ
Cytotherapy; 2024 Apr; 26(4):351-359. PubMed ID: 38349310
[TBL] [Abstract][Full Text] [Related]
5. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
[TBL] [Abstract][Full Text] [Related]
6. Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Omer AK; Weisdorf DJ; Lazaryan A; Shanley R; Blazar BR; MacMillan ML; Brunstein C; Bejanyan N; Arora M
Biol Blood Marrow Transplant; 2016 May; 22(5):879-83. PubMed ID: 26743342
[TBL] [Abstract][Full Text] [Related]
7. Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis.
Troullioud Lucas AG; Lindemans CA; Bhoopalan SV; Dandis R; Prockop SE; Naik S; Keerthi D; de Koning C; Sharma A; Nierkens S; Boelens JJ
Cytotherapy; 2023 Sep; 25(9):977-985. PubMed ID: 37330731
[TBL] [Abstract][Full Text] [Related]
8. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
[TBL] [Abstract][Full Text] [Related]
9. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.
Admiraal R; van Kesteren C; Jol-van der Zijde CM; Lankester AC; Bierings MB; Egberts TC; van Tol MJ; Knibbe CA; Bredius RG; Boelens JJ
Lancet Haematol; 2015 May; 2(5):e194-203. PubMed ID: 26688094
[TBL] [Abstract][Full Text] [Related]
10. Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.
Gooptu M; Kim HT; Chen YB; Rybka W; Artz A; Boyer M; Johnston L; McGuirk J; Shea TC; Jagasia M; Shaughnessy PJ; Reynolds CG; Fields M; Alyea EP; Ho VT; Glavin F; Dipersio JF; Westervelt P; Ritz J; Soiffer RJ
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2216-2223. PubMed ID: 30006305
[TBL] [Abstract][Full Text] [Related]
11. T cell reconstitution in allogeneic haematopoietic stem cell transplantation: prognostic significance of plasma interleukin-7.
Kielsen K; Jordan KK; Uhlving HH; Pontoppidan PL; Shamim Z; Ifversen M; Heilmann C; Nielsen CH; Sengeløv H; Ryder LP; Müller KG
Scand J Immunol; 2015 Jan; 81(1):72-80. PubMed ID: 25263171
[TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.
de Koning C; Admiraal R; Nierkens S; Boelens JJ
Blood Adv; 2018 Feb; 2(4):428-432. PubMed ID: 29487057
[TBL] [Abstract][Full Text] [Related]
13. γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation.
Wu N; Liu R; Liang S; Gao H; Xu LP; Zhang XH; Liu J; Huang XJ
Front Immunol; 2021; 12():687961. PubMed ID: 34335589
[TBL] [Abstract][Full Text] [Related]
14. High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.
Lu SY; Liu KY; Liu DH; Xu LP; Huang XJ
Clin Exp Immunol; 2011 Aug; 165(2):264-77. PubMed ID: 21635226
[TBL] [Abstract][Full Text] [Related]
15. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
[TBL] [Abstract][Full Text] [Related]
16. Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.
Rezvani AR; Storer BE; Storb RF; Mielcarek M; Maloney DG; Sandmaier BM; Martin PJ; McDonald GB
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1594-601. PubMed ID: 21806949
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation.
Pasic I; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Mattsson J; Michelis FV
Ann Hematol; 2020 Jun; 99(6):1377-1387. PubMed ID: 32382774
[TBL] [Abstract][Full Text] [Related]
18. Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation.
Admiraal R; Lindemans CA; van Kesteren C; Bierings MB; Versluijs AB; Nierkens S; Boelens JJ
Blood; 2016 Dec; 128(23):2734-2741. PubMed ID: 27702800
[TBL] [Abstract][Full Text] [Related]
19. Viral PCR positivity in stool before allogeneic hematopoietic cell transplantation is strongly associated with acute intestinal graft-versus-host disease.
van Montfrans J; Schulz L; Versluys B; de Wildt A; Wolfs T; Bierings M; Gerhardt C; Lindemans C; Wensing A; Boelens JJ
Biol Blood Marrow Transplant; 2015 Apr; 21(4):772-4. PubMed ID: 25598276
[TBL] [Abstract][Full Text] [Related]
20. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.
Clave E; Busson M; Douay C; Peffault de Latour R; Berrou J; Rabian C; Carmagnat M; Rocha V; Charron D; Socié G; Toubert A
Blood; 2009 Jun; 113(25):6477-84. PubMed ID: 19258596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
